MIAMI, June 22, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal Caribbean Group, helping provide a safe environment for travelers.
OPKO’s BioReference Laboratories Announces COVID-19 Testing Program For Royal Caribbean Group
MIAMI, June 22, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal
Related Posts
MFA Financial Q2 EPS $0.13 Beats $0.08 Estimate
MFA Financial (NYSE:MFA) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.08 by 62.5 percent. This is a 31.58 percent decrease over earnings of $0.19 per share from the same
Keybanc Initiates Coverage On Black Stone Minerals with Overweight Rating, Announces Price Target of $22
Keybanc analyst Tim Rezvan initiates coverage on Black Stone Minerals (NYSE:BSM) with a Overweight rating and announces Price Target of $22.
BMO Capital Upgrades Celestica to Outperform, Lowers Price Target to $12.5
BMO Capital analyst Thanos Moschopoulos upgrades Celestica (NYSE:CLS) from Market Perform to Outperform and lowers the price target from $13 to $12.5.